Browse > Article

Bloodstream Infections in Children with Cancer between 2005 and 2008 in a Single Center  

Kim, Ji Hye (Department of Pediatrics, Hanyang University School of Medicine)
Kim, Hyung Jin (Department of Pediatrics, Hanyang University School of Medicine)
Lim, Yeon Jung (Department of Pediatrics, Hanyang University School of Medicine)
Lee, Young Ho (Department of Pediatrics, Hanyang University School of Medicine)
Oh, Sung Hee (Department of Pediatrics, Hanyang University School of Medicine)
Publication Information
Pediatric Infection and Vaccine / v.17, no.1, 2010 , pp. 36-48 More about this Journal
Abstract
Purpose : In children on anticancer chemotherapy, bloodstream infections (BSIs) are a major cause of morbidity and mortality. We investigated febrile episodes and bloodstream infections in pediatric cancer patients to guide proper selection of empiric antibiotics for febrile pediatric hemato-oncologic patients. Methods : All febrile episodes treated in the division of hematology-oncology, the department of pediatrics, Hanyang University Hospital, between July 2005 and June 2008 were reviewed. Episodes with and without bloodstream infections were compared. Results : Forty cases (18.9%, 25 patients) of BSI occurred in 212 febrile episodes (63 patients). Thirty-seven cases (23.6%, 22 patients) of BSI occurred in 157 febrile episodes with neutropenia (54 patients). Microorganisms identified in BSI corresponded to 23 gram-positive bacteria (51.2%), 20 gram-negative bacteria (44.5%), and 2 fungi (4.4%). Rates of BSI between those who had received umbilical cord blood transplantation and those who had received transplantation from other source were significantly different (55.0% vs. 7.7%, P =0.001). No differences in mortality rate were observed among organisms in BSI patients. For febrile episodes the rate of BSI was higher among those with Chemoport than those with Hickman catheter (P =0.029) and gram-positive pathogens were more likely to be associated with Chemoport (P =0.001). Conclusion : The study showed the rate of BSI, distribution of pathogens with regard to neutropenia, transplantation, central venous catheters, and antimicrobial susceptibility of pathogens in order to help guide in the choice of optimal empiric antibiotics in pediatric febrile neutropenic hemato-oncologic patients.
Keywords
Fever; Neutropenia; Neoplasms; Bacteremia; Catheters; Indwelling;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Pizzo PA. Evaluation of fever in the patient with cancer. Eur J Cancer Clin Oncol 1989;25 Suppl 2:886-90.
2 Mary JF, William AC, Michael ND, George E, David WH, Janet FH, et al. Performance standards for antimicrobial susceptibility testing. Twelfth international supplement. P66-7, villanova, PA, National Committee for Clinical Laboratory Standards 2002.
3 Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, et al. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002;34:730-51.   DOI   ScienceOn
4 Madani TA. Clnical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection 2000;28: 367-71.   DOI   ScienceOn
5 Gaytan-Martinez J, Mateos-Garcia E, Sanchez-cortes E, Gonzalesz-Llaven J, Casanova-Cardiel LJ, Fuentes- Allen JL. Microbiological findings in febrile neutropenia. Arch Med Res 2000;31:399-94.   DOI   ScienceOn
6 Serody JS. Fever in immunocompromised patients. N Engl J Med 2000;342:217-9.   DOI   ScienceOn
7 Elting L, Rubenstein E, Rolston K, Bodey G. Outcomes of bacteremia in patients with cancer and neutropenia : Observations from two decades of epidemiological and clinical trials. Clin Infect Dis 1997;25:247-59.   DOI   ScienceOn
8 Ariffin H, Navaratnam P, Lin HP. Surveillance study of bacteremic episodes in febrile neutropenic children. Int J Clin Pract 2002;56:237-40.
9 Ammann RA, Hirt A, Luthy AR, Aebi C. Predicting bacteremia in children with fever and chemotherapy-induced neutropenia. Pediatr Infect Dis J 2004;23:61-7.   DOI   ScienceOn
10 Carlisle PS, Gucalp R, Wiernik PH. Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol 1993;14:320-4.   DOI   ScienceOn
11 Ashkenazi S, Leibovici L, Samra Z, Konisberger H, Drucker M. Risk factors for mortality due to bacteremia and fungemia in childhood. Clin Infect Dis 1992;14:949-51.   DOI   ScienceOn
12 Guven GS, Uzun O, Cakir B, Akova M, Unal S. Infectious complications in patients with hematological malignancies consulted by the infectious disease team: a retrospective cohort study (1997-2001). Support Care Cancer 2006;14:52-5.   DOI   ScienceOn
13 Pizzo PA. Management of fever in patient with cancer and treatment-induced neutropenia. N Engl J Med 1993;328:1323-32.   DOI   ScienceOn
14 De Vita VT Jr, Hellman S, Rosenberg S. Cancer, principles & practice of oncology. 6th edition. Philadelphia (PA): Lippincott Williams % Wilkins Publications; 2001.
15 Chaberny IF. Ruseva E, Sohr D, Buchholz S, Ganser A, Mattner F, et al. Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies. Ann Hematol 2009;88:907-12.   DOI   ScienceOn
16 Mirro J Jr, Rao BN, Stokes DC, Austin BA, Kumar M, Dahl GV, et al. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol 1989;7:214-22.   DOI
17 Viscoli C, Castagnola E, Giacchino M, Cesaro S, Properzi E, Tucci F, et al. Bloodstream infections in children with cancer : a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. Eur J Cancer 1999;35:770-4.   DOI   ScienceOn
18 Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults : results from four EORTC studies. International Antimicrobial Therapy Cooperatve Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997;99:580-8.   DOI   ScienceOn
19 Marena C, Zecca M, Carenini ML, Bruschi A, Bassi ML, Olivieri P, et al. Incidence of, and risk factors for, nosocomial infections among hematopoietic stem cell transplantation recipients, with impact on procedure-related mortality. Infect Control Hosp Epidemiol 2001;22: 510-7.   DOI   ScienceOn
20 Ingram J, Weitzman S, Greenberg ML, Parkin P, Filler R. Complications of indwelling venous access lines in the pediatric hematology patient : a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol 1991;13:130-6.   DOI
21 Mueller BU, Skelton J, Callender DP, Marshall D, Gress J, Longo D, et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992;12: 1943-8.
22 Hengartner H, Berger C, Nadal D, Niggli FK, Grotzer MA. Port-A-Cath infections in children with cancer. Eur J Cancer 2004;40:2452-8.   DOI   ScienceOn
23 Sheretz RJ, Raad II, Balani A, Koo L, Rand K. Threeyear experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol 1990;28:76-82.
24 Richards MJ, Edwards JR, Culver DH, Gaynes RP. Nosocomial bloodstream infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 1997;27:887- 92.
25 Raad II. Intravascular-catheter-related infections. Lancet 1998;351:894-98.
26 Raad II, Darouiche RO. Catheter-related septicemia : risk reduction. Infect Med 1996;13:807-12.
27 Choi EH, Pyo JW, Park JY, Kwon KB, Yun BY, Shin HY, et al. Infections in children with neoplastic disease. J Korean Pediatr Soc 1995;38:366-77.
28 Yun BY, Lee HJ. Septicemia in children with neoplastic disease. J Korean Pediatr Soc 1992;35:1481-91.
29 Kim YH, Lee HD, Hah JO. Bacteremia in pediatric cancer patients: causative organisms and antibiotic sensitivities. Korean J Pediatr 2005;48:619-23.
30 Park SM, Choe BK, Kim CS, Kim JS, Kim HS, Ryoo NH. Bacteremia in pediatric cancer patients: a single center study. Korean J Pediatr 2006;49:882-8.   DOI
31 Park HW, Youn HS, Im HJ, Kim MN, Seo JJ, Moon HN. Risk factors of bloodstream infection associated mortality in pediatric patients with hemato-oncologic disease. Korean J Hematol 2007;42:343-52.   DOI   ScienceOn
32 Urrea M, Rives S, Cruz O, Navarro A, Garcia JJ, Estella J. Nosocoial infections among pediatric hematology/ oncology patients: Results of a prospective incidence study. Am J Infect Control 2004;32:205-8.   DOI   ScienceOn
33 Simon A, Fleischhack G, Hassan C, Bode U, Engelhart S, Kramer M. Surveillance for nosocomial and central line related infections among pediatric hematologyoncology patients. Infect Control Hosp Epidemiol 2000;21:592-6.   DOI   ScienceOn
34 Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:1103-10.   DOI   ScienceOn
35 Zinner SH, Changing epidemiology of infections in patients with neutropenia and cancer : emphasis on gram positive and resistant bacteria. Clin Infect Dis 1999;29: 490-4.   DOI   ScienceOn
36 Collin BA, Leather HL, Wingard JR, Ramhal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001;33:947-53.   DOI   ScienceOn
37 Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239-44.   DOI   ScienceOn
38 Kim SH, Lee YA, Eun BW, Kim NH, Lee JA, Kang HJ, et al. Etiological agents isolated from blood in children with hemato-oncologic diseases (2002-2005). Korean J Pediatr 2007;50:56-64.   DOI   ScienceOn